0001752724-21-114472.txt : 20210527 0001752724-21-114472.hdr.sgml : 20210527 20210527093730 ACCESSION NUMBER: 0001752724-21-114472 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210527 PERIOD START: 20211231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Morgan Stanley China A Share Fund, Inc. CENTRAL INDEX KEY: 0001368493 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-21926 FILM NUMBER: 21968998 BUSINESS ADDRESS: STREET 1: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 800-231-2608 MAIL ADDRESS: STREET 1: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 NPORT-P 1 primary_doc.xml NPORT-P false 0001368493 XXXXXXXX Morgan Stanley China A Share Fund, Inc. 811-21926 0001368493 54930045HQ1UNO6FR635 522 FIFTH AVENUE NEW YORK 10036 800-231-2608 Morgan Stanley China A Share Fund, Inc. 54930045HQ1UNO6FR635 2021-12-31 2021-03-31 N 557671266.82 1148836.07 556522430.75 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 4826572.09000000 N Mayinglong Pharmaceutical Group Co Ltd N/A Mayinglong Pharmaceutical Group Co Ltd 000000000 1936140.00000000 NS 5490898.95000000 0.986644678921 Long EC CORP CN N 1 N N N Hefei Meiya Optoelectronic Technology Inc N/A Hefei Meiya Optoelectronic Technology Inc 000000000 1210000.00000000 NS 7806392.07000000 1.402709331855 Long EC CORP CN N 1 N N N UNIVERSAL SCIENTIFIC CONV N/A UNIVERSAL SCIENTIFIC CONV CHINA A SHANGHAI 20270303 000000000 10498000.00000000 PA 1601525.55000000 0.287773764633 Long DBT CORP CN N 2 2027-03-03 Variable 1.00000000 N N N N N Universal Scientific Industrial Shanghai Co Ltd Universal Scientific Industrial Shanghai Co Ltd CNY XXXX N N N Shanghai Pharmaceuticals Holding Co Ltd 30030029J1KKCBY19820 Shanghai Pharmaceuticals Holding Co Ltd 000000000 14602800.00000000 NS 28664247.69000000 5.150600605867 Long EC CORP CN N 1 N N N Southern Publishing & Media Co Ltd 30030038NR4CDSDY3592 Southern Publishing & Media Co Ltd 000000000 1973399.00000000 NS 2411430.36000000 0.433303354323 Long EC CORP CN N 1 N N N Guangzhou Restaurant Group Co Ltd N/A Guangzhou Restaurant Group Co Ltd 000000000 2211491.00000000 NS 12752762.75000000 2.291509208858 Long EC CORP CN N 1 N N N Bank of Communications Co Ltd 549300AX1UM10U30HK09 Bank of Communications Co Ltd 000000000 23236539.00000000 NS 17547043.18000000 3.152980403027 Long EC CORP CN N 1 N N N Guangdong South New Media Co Ltd 3003005EVA5GW7PLTK26 Guangdong South New Media Co Ltd 000000000 1233314.00000000 NS 9061236.04000000 1.628188827499 Long EC CORP CN N 1 N N N Shanghai Milkground Food Tech Co Ltd N/A Shanghai Milkground Food Tech Co Ltd 000000000 1555600.00000000 NS 13500851.87000000 2.425931305555 Long EC CORP CN N 1 N N N Jiangsu Expressway Co Ltd 529900UWWTWZ6AKLYD43 Jiangsu Expressway Co Ltd 000000000 6998591.00000000 NS 10623337.98000000 1.908878671014 Long EC CORP CN N 1 N N N Jiangsu Hengrui Medicine Co Ltd N/A Jiangsu Hengrui Medicine Co Ltd 000000000 582723.00000000 NS 8186569.19000000 1.471022323209 Long EC CORP CN N 1 N N N China Merchants Property Operation & Service Co Ltd N/A China Merchants Property Operation & Service Co Ltd 000000000 1245600.00000000 NS 3752951.95000000 0.674357715454 Long EC CORP CN N 1 N N N Foxconn Industrial Internet Co Ltd N/A Foxconn Industrial Internet Co Ltd 000000000 14518496.00000000 NS 31827732.65000000 5.719038603189 Long EC CORP CN N 1 N N N Industrial & Commercial Bank of China Ltd 5493002ERZU2K9PZDL40 Industrial & Commercial Bank of China Ltd 000000000 29450683.00000000 NS 24890432.31000000 4.472493997493 Long EC CORP CN N 1 N N N Yixintang Pharmaceutical Group Co Ltd 300300NE1YJT00E9JD69 Yixintang Pharmaceutical Group Co Ltd 000000000 56000.00000000 NS 396057.97000000 0.071166578041 Long EC CORP CN N 1 N N N Chacha Food Co Ltd 300300AJZ9YPIRBJZN87 Chacha Food Co Ltd 000000000 1686459.00000000 NS 12609207.57000000 2.265714169509 Long EC CORP CN N 1 N N N Universal Scientific Industrial Shanghai Co Ltd N/A Universal Scientific Industrial Shanghai Co Ltd 000000000 7797832.00000000 NS 23018771.81000000 4.136180419355 Long EC CORP CN N 1 N N N Joincare Pharmaceutical Group Industry Co Ltd 3003006PUWUKPH72TS46 Joincare Pharmaceutical Group Industry Co Ltd 000000000 2308482.00000000 NS 4514834.36000000 0.811258290868 Long EC CORP CN N 1 N N N Jiangsu Yanghe Brewery Joint-Stock Co Ltd 655600IQ7FXTTBKI8H68 Jiangsu Yanghe Brewery Joint-Stock Co Ltd 000000000 263500.00000000 NS 6620663.62000000 1.189649015777 Long EC CORP CN N 1 N N N Shenzhen Airport Co Ltd 3003009W045RIKRBZI44 Shenzhen Airport Co Ltd 000000000 5179100.00000000 NS 7016080.55000000 1.260700407087 Long EC CORP CN N 1 N N N Unisplendour Corp Ltd 300300Z3RHZRXCNTRC53 Unisplendour Corp Ltd 000000000 1873877.00000000 NS 5671658.23000000 1.019124821681 Long EC CORP CN N 1 N N N Petpal Pet Nutrition Technology Co Ltd N/A Petpal Pet Nutrition Technology Co Ltd 000000000 585600.00000000 NS 2680091.53000000 0.481578348313 Long EC CORP CN N 1 N N N China Merchants Shekou Industrial Zone Holdings Co Ltd 300300T3ACALX7NIPW13 China Merchants Shekou Industrial Zone Holdings Co Ltd 000000000 7490877.00000000 NS 14021824.68000000 2.519543491014 Long EC CORP CN N 1 N N N Yunnan Baiyao Group Co Ltd N/A Yunnan Baiyao Group Co Ltd 000000000 1110200.00000000 NS 20410404.58000000 3.667490015181 Long EC CORP CN N 1 N N N Yantai China Pet Foods Co Ltd 655600CR5H76LMBJYO93 Yantai China Pet Foods Co Ltd 000000000 1001776.00000000 NS 6812993.76000000 1.224208294860 Long EC CORP CN N 1 N N N Pharmaron Beijing Co Ltd 300300JYXHGVS5SNGG54 Pharmaron Beijing Co Ltd 000000000 328800.00000000 NS 6213030.45000000 1.116402521570 Long EC CORP CN Y 1 N N N Midea Group Co Ltd 3003003TRPHLHZD2IF61 Midea Group Co Ltd 000000000 945392.00000000 NS 11859585.68000000 2.131016653545 Long EC CORP CN N 1 N N N Chacha Food Co Ltd 300300AJZ9YPIRBJZN87 Chacha Food Co Ltd 000000000 360966.00000000 NS 2698847.24000000 0.484948510765 Long EC CORP CN N 1 N N N China Merchants Property Operation & Service Co Ltd N/A China Merchants Property Operation & Service Co Ltd 000000000 5879967.00000000 NS 17716147.71000000 3.183366335499 Long EC CORP CN N 1 N N N YUNNAN BAIYAO GROUP CO., LTD N/A YUNNAN BAIYAO GROUP CO., LTD 000000000 407000.00000000 NS 7220580.48000000 1.297446442593 Long EC CORP CN N 2 N N N Morgan Stanley & Co. LLC 549300BI6Y5SI6BYPB26 Morgan Stanley Institutional Liquidity Funds - Government Portfolio 61747C707 2983428.22000000 NS USD 2983428.22000000 0.536084092060 Long STIV RF US N 1 N N N Guangzhou Haige Communications Group Inc Co 300300DDUUICKXUNQI85 Guangzhou Haige Communications Group Inc Co 000000000 3111802.00000000 NS 4804185.54000000 0.863251016410 Long EC CORP CN N 1 N N N Weichai Power Co Ltd 529900OKTPKBG85F9502 Weichai Power Co Ltd 000000000 1512300.00000000 NS 4438848.51000000 0.797604600414 Long EC CORP CN N 1 N N N Kweichow Moutai Co Ltd N/A Kweichow Moutai Co Ltd 000000000 34001.00000000 NS 10420748.89000000 1.872475989145 Long EC CORP CN N 1 N N N China Vanke Co Ltd 529900E66UJ2DWY7KW55 China Vanke Co Ltd 000000000 620000.00000000 NS 2428448.31000000 0.436361263413 Long EC CORP CN N 1 N N N China Yangtze Power Co Ltd 3003008VX8JFJXA6QP74 China Yangtze Power Co Ltd 000000000 5274207.00000000 NS 17250800.62000000 3.099749384180 Long EC CORP CN N 1 N N N Inner Mongolia Yili Industrial Group Co Ltd 3003002Q2A863JPQFH06 Inner Mongolia Yili Industrial Group Co Ltd 000000000 2061115.00000000 NS 12586793.81000000 2.261686702014 Long EC CORP CN N 1 N N N China Resources Sanjiu Medical & Pharmaceutical Co Ltd N/A China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000000000 13159338.00000000 NS 49104104.88000000 8.823382880331 Long EC CORP CN N 1 N N N China Pacific Insurance Group Co Ltd 529900BA5ILEL308WX03 China Pacific Insurance Group Co Ltd 000000000 2663200.00000000 NS 10499875.23000000 1.886693985694 Long EC CORP CN N 1 N N N Haier Smart Home Co Ltd 3003002BYTNGNJTWSH07 Haier Smart Home Co Ltd 000000000 2679432.00000000 NS 12745185.32000000 2.290147641097 Long EC CORP CN N 1 N N N Beijing Thunisoft Corp Ltd 300300ARLN2H6DSZJ004 Beijing Thunisoft Corp Ltd 000000000 8842020.00000000 NS 25588576.57000000 4.597941638311 Long EC CORP CN N 1 N N N Huatai Securities Co Ltd 3003009ABT0UCWO79Q77 Huatai Securities Co Ltd 000000000 6762815.00000000 NS 17497687.63000000 3.144111838658 Long EC CORP CN N 1 N N N Petpal Pet Nutrition Technology Co Ltd N/A Petpal Pet Nutrition Technology Co Ltd 000000000 2447563.00000000 NS 11201661.33000000 2.012796018824 Long EC CORP CN N 1 N N N Joincare Pharmaceutical Group Industry Co Ltd 3003006PUWUKPH72TS46 Joincare Pharmaceutical Group Industry Co Ltd 000000000 1096100.00000000 NS 2143707.40000000 0.385196944732 Long EC CORP CN N 1 N N N China Vanke Co Ltd 529900E66UJ2DWY7KW55 China Vanke Co Ltd 000000000 1675272.00000000 NS 7667148.74000000 1.377689077090 Long EC CORP CN N 1 N N N Shandong Publishing & Media Co Ltd N/A Shandong Publishing & Media Co Ltd 000000000 15766834.00000000 NS 14311618.96000000 2.571615835989 Long EC CORP CN N 1 N N N Jiangsu Nhwa Pharmaceutical Co Ltd N/A Jiangsu Nhwa Pharmaceutical Co Ltd 000000000 6884709.00000000 NS 15575932.03000000 2.798796808424 Long EC CORP CN N 1 N N N Yixintang Pharmaceutical Group Co Ltd 300300NE1YJT00E9JD69 Yixintang Pharmaceutical Group Co Ltd 000000000 555000.00000000 NS 3925217.39000000 0.705311623236 Long EC CORP CN N 1 N N N 2021-04-27 Morgan Stanley China A Share Fund, Inc. Francis Smith Francis Smith Principal Financial Officer XXXX NPORT-EX 2 NPORT_MGGN_5510663576.htm

 

Morgan Stanley China A Share Fund, Inc.
Portfolio of Investments
First Quarter Report
March 31, 2021 (unaudited)

 

   Shares   Value
(000)
 
Common Stocks  (98.5%)          
Banks  (7.6%)          
Bank of Communications Co., Ltd., Class A   23,236,539   $17,547 
Industrial & Commercial Bank of China Ltd., Class A   29,450,683    24,891 
         42,438 
Beverages  (3.1%)          
Jiangsu Yanghe Brewery Joint-Stock Co., Ltd., Class A   263,500    6,620 
Kweichow Moutai Co., Ltd., Class A   34,001    10,421 
         17,041 
Capital Markets  (3.1%)          
Huatai Securities Co. Ltd., Class A   6,762,815    17,498 
           
Communications Equipment  (0.9%)          
Guangzhou Haige Communications Group, Inc. Co., Class A   3,111,802    4,804 
           
Electronic Equipment, Instruments & Components  (10.9%)          
Foxconn Industrial Internet Co. Ltd., Class A   14,518,496    31,828 
Unisplendour Corp. Ltd., Class A   1,873,877    5,671 
Universal Scientific Industrial Shanghai Co., Ltd., Class A   7,797,832    23,019 
         60,518 
Food & Staples Retailing  (0.8%)          
Yixintang Pharmaceutical Group Co. Ltd., Class A   611,000    4,321 
           
Food Products  (11.2%)          
Chacha Food Co. Ltd., Class A   2,047,425    15,308 
Inner Mongolia Yili Industrial Group Co., Ltd., Class A   2,061,115    12,587 
Petpal Pet Nutrition Technology Co. Ltd., Class A (a)   3,033,163    13,881 
Shanghai Milkground Food Tech Co. Ltd., Class A (a)   1,555,600    13,501 
Yantai China Pet Foods Co. Ltd., Class A   1,001,776    6,813 
         62,090 
Health Care Providers & Services  (5.1%)          
Shanghai Pharmaceuticals Holding Co., Ltd. H Shares (b)   14,602,800    28,664 
           
Hotels, Restaurants & Leisure  (2.3%)          
Guangzhou Restaurant Group Co. Ltd., Class A   2,211,491    12,753 
           
Household Durables  (4.4%)          
Haier Smart Home Co., Ltd., Class A   2,679,432    12,745 
Midea Group Co., Ltd., Class A   945,392    11,860 
         24,605 
Independent Power & Renewable Electricity Producer  (3.1%)          
China Yangtze Power Co., Ltd., Class A   5,274,207    17,251 
           
Insurance  (1.9%)          
China Pacific Insurance Group Co., Ltd. H Shares (b)   2,663,200    10,500 
           
Life Sciences Tools & Services  (1.1%)          
Pharmaron Beijing Co. Ltd., Class H (b)   328,800    6,213 
           
Machinery  (2.2%)          
Hefei Meiya Optoelectronic Technology, Inc., Class A   1,210,000    7,806 
Weichai Power Co. Ltd., Class A   1,512,300    4,439 
         12,245 

 

 

 

Morgan Stanley China A Share Fund, Inc.
Portfolio of Investments
First Quarter Report
March 31, 2021 (unaudited)(cont’d)

 

Media  (4.6%)          
Guangdong South New Media Co. Ltd., Class A   1,233,314    9,061 
Shandong Publishing & Media Co. Ltd., Class A   15,766,834    14,312 
Southern Publishing & Media Co., Ltd., Class A   1,973,399    2,411 
         25,784 
Pharmaceuticals  (20.2%)          
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Class A   13,159,338    49,104 
Jiangsu Hengrui Medicine Co., Ltd., Class A   582,723    8,186 
Jiangsu Nhwa Pharmaceutical Co. Ltd., Class A   6,884,709    15,576 
Joincare Pharmaceutical Group Industry Co. Ltd., Class A   3,404,582    6,659 
Mayinglong Pharmaceutical Group Co. Ltd., Class A   1,936,140    5,491 
Yunnan Baiyao Group Co., Ltd., Class A   1,110,200    20,410 
Yunnan Baiyao Group Co., Ltd. (c)   407,000    7,221 
         112,647 
Real Estate Management & Development  (8.2%)          
China Merchants Property Operation & Service Co. Ltd., Class A   7,125,567    21,469 
China Merchants Shekou Industrial Zone Holdings Co., Ltd., Class A   7,490,877    14,022 
China Vanke Co., Ltd., Class A   1,675,272    7,667 
China Vanke Co., Ltd. H Shares (b)   620,000    2,429 
         45,587 
Software  (4.6%)          
Beijing Thunisoft Corp., Ltd., Class A   8,842,020    25,589 
           
Transportation Infrastructure  (3.2%)          
Jiangsu Expressway Co., Ltd., Class A   6,998,591    10,623 
Shenzhen Airport Co., Ltd., Class A   5,179,100    7,016 
         17,639 
Total Common Stocks (Cost $524,274)        548,187 
 
Corporate Bonds  (0.3%)          
Information Technology  (0.3%)          
Universal Scientific Industrial Shanghai Co., Ltd., Class A
1.00%, 3/3/27   (Cost $1,623)
   10,498    1,602 
Short-Term Investment  (0.5%)          
Investment Company  (0.5%)
Morgan Stanley Institutional Liquidity Funds - Government Portfolio - Institutional Class (d) (Cost $2,983)
   2,983,428    2,983 
Total Investments (99.3%) (Cost $528,880)  (e)(f)        552,772 
Other Assets in Excess of Liabilities (0.7%)        3,750 
Net Assets (100.0%)       $556,522 

 

 

 

Morgan Stanley China A Share Fund, Inc.
Portfolio of Investments
First Quarter Report
March 31, 2021 (unaudited)(cont’d)

 

 

(a) Non-income producing security.
(b) Security trades on the Hong Kong exchange.
(c) Security cannot be offered for public resale without first being registered under the Securities Act of 1933 and related rules (“restricted security”). Acquisition date represents the day on which an enforceable right to acquire such security is obtained and is presented along with related cost in the security description. The Fund has registration rights for certain restricted securities. Any costs related to such registration are borne by the issuer. The aggregate value of restricted securities (excluding 144A holdings) at March 31, 2021 amounts to approximately $7,221,000 and represents 1.3% of net assets.
(d) The Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Government Portfolio - (the "Liquidity Funds"), an open-end management investment company managed by the Adviser. Advisory fees paid by the Fund are reduced by an amount equal to its pro-rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Funds. For the three months ended March 31, 2021, advisory fees paid were reduced by approximately $1,000 relating to the Fund's investment in the Liquidity Funds.
(e) The Fund is permitted to purchase and sell securities ("cross-trade") from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Directors in compliance with Rule 17a-7 under the Act (the "Rule"). Each cross-trade is executed at the current market price in compliance with provisions of the Rule. For the three months ended March 31, 2021, the Fund did not engage in any cross-trade transactions.
(f) At March 31, 2021, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is approximately $44,851,000 and the aggregate gross unrealized depreciation is approximately $20,959,000, resulting in net unrealized appreciation of approximately $23,892,000.
 

 

 

 

Portfolio Composition     
Classification   Percentage of
Total Investments
 
Other*   36.3%
Pharmaceuticals   20.4 
Food Products   11.2 
Electronic Equipment, Instruments & Components   11.0 
Real Estate Management & Development   8.2 
Banks   7.7 
Health Care Providers & Services   5.2 
Total Investments   100.0%

 

 

* Industries and/or investment types representing less than 5% of total investments.

 

 

 

Morgan Stanley China A Share Fund, Inc.

 

Notes to the Portfolio of Investments ▪ March 31, 2021 (unaudited)

 

Security Valuation: (1) An equity portfolio security listed or traded on an exchange is valued at its latest reported sales price (or at the exchange official closing price if such exchange reports an official closing price), and if there were no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant exchanges. If only bid prices are available then the latest bid price may be used. Listed equity securities not traded on the valuation date with no reported bid and asked prices available on the exchange are valued at the mean between the current bid and asked prices obtained from one or more reputable brokers or dealers. In cases where a security is traded on more than one exchange, the security is valued on the exchange designated as the primary market; (2) all other equity portfolio securities for which over-the-counter (“OTC”) market quotations are readily available are valued at the latest reported sales price (or at the market official closing price if such market reports an official closing price), and if there was no trading in the security on a given day and if there is no official closing price from relevant markets for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant markets. An unlisted equity security that does not trade on the valuation date and for which bid and asked prices from the relevant markets are unavailable is valued at the mean between the current bid and asked prices obtained from one or more reputable brokers or dealers; (3) certain portfolio securities may be valued by an outside pricing service/vendor approved by the Fund's Board of Directors (the "Directors"). The pricing service/vendor may employ a pricing model that takes into account, among other things, bids, yield spreads and/or other market data and specific security characteristics. Alternatively, if a valuation is not available from an outside pricing service/vendor, and the security trades on an exchange, the security may be valued at its latest reported sale price (or at the exchange official closing price if such exchange reports an official closing price), prior to the time when assets are valued. If there are no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available in the relevant exchanges. If only bid prices are available then the latest bid price may be used. If Morgan Stanley Investment Management Inc. (the “Adviser”), a wholly-owned subsidiary of Morgan Stanley, determines that the price provided by the outside pricing service/vendor or exchange does not reflect the security’s fair value or is unable to provide a price, prices from brokers or dealers may also be utilized. In these circumstances, the value of the security will be the mean of bid and asked prices obtained from brokers or dealers; (4) when market quotations are not readily available, including circumstances under which the Adviser determines that the closing price, last sale price or the mean between the last reported bid and asked prices are not reflective of a security’s market value, portfolio securities are valued at their fair value as determined in good faith under procedures established by and under the general supervision of the Directors. Occasionally, developments affecting the closing prices of securities and other assets may occur between the times at which valuations of such securities are determined (that is, close of the foreign market on which the securities trade) and the close of business of the New York Stock Exchange (“NYSE”). If developments occur during such periods that are expected to materially affect the value of such securities, such valuations may be adjusted to reflect the estimated fair value of such securities as of the close of the NYSE, as determined in good faith by the Directors or by the Adviser using a pricing service and/or procedures approved by the Directors; (5) quotations of foreign portfolio securities, other assets and liabilities and forward contracts stated in foreign currency are translated into U.S. dollar equivalents at the prevailing market rates prior to the close of the NYSE; and (6) investments in mutual funds, including the Morgan Stanley Institutional Liquidity Funds, are valued at the net asset value as of the close of each business day.

 

The Directors have responsibility for determining in good faith the fair value of the investments, and the Directors may appoint others, such as the Fund's Adviser or a valuation committee, to assist the Directors in determining fair value and to make the actual calculations pursuant to the fair valuation methodologies previously approved by the Directors. Under procedures approved by the Directors, the Fund's Adviser has formed a Valuation Committee whose members are approved by the Directors. The Valuation Committee provides administration and oversight of the Fund’s valuation policies and procedures, which are reviewed at least annually by the Directors. These procedures allow the Fund to utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.

 

 

 

Fair Value Measurement: Financial Accounting Standards Board (“FASB”) Accounting Standards CodificationTM ("ASC") 820, "Fair Value Measurement" (“ASC 820”), defines fair value as the value that the Fund would receive to sell an investment or pay to transfer a liability in a timely transaction with an independent buyer in the principal market, or in the absence of a principal market, the most advantageous market for the investment or liability. ASC 820 establishes a three-tier hierarchy to distinguish between (1) inputs that reflect the assumptions market participants would use in valuing an asset or liability developed based on market data obtained from sources independent of the reporting entity (observable inputs) and (2) inputs that reflect the reporting entity's own assumptions about the assumptions market participants would use in valuing an asset or liability developed based on the best information available in the circumstances (unobservable inputs) and to establish classification of fair value measurements for disclosure purposes. Various inputs are used in determining the value of the Fund's investments. The inputs are summarized in the three broad levels listed below:

 

Level 1 – unadjusted quoted prices in active markets for identical investments

 

Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

 

Level 3 – significant unobservable inputs including the Fund’s own assumptions in determining the fair value of investments. Factors considered in making this determination may include, but are not limited to, information obtained by contacting the issuer, analysts, or the appropriate stock exchange (for exchange-traded securities), analysis of the issuer's financial statements or other available documents and, if necessary, available information concerning other securities in similar circumstances.

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities and the determination of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each security.

 

 

 

The following is a summary of the inputs used to value the Fund's investments as of March 31, 2021:

 

Investment Type  Level 1
Unadjusted
quoted
prices
(000)
   Level 2
Other
significant
observable
inputs
(000)
   Level 3
Significant
unobservable
inputs
(000)
   Total
(000)
 
Assets:                    
Common Stocks                    
Banks  $42,438   $   $                —   $42,438 
Beverages   17,041       —        17,041 
Capital Markets   17,498            17,498 
Communications Equipment   4,804            4,804 
Electronic Equipment, Instruments & Components   60,518            60,518 
Food & Staples Retailing   4,321            4,321 
Food Products   62,090            62,090 
Health Care Providers & Services   28,664            28,664 
Hotels, Restaurants & Leisure   12,753            12,753 
Household Durables   24,605            24,605 
Independent Power & Renewable Electricity Producers   17,251            17,251 
Insurance   10,500            10,500 
Life Sciences Tools & Services   6,213            6,213 
Machinery   12,245            12,245 
Media   25,784            25,784 
Pharmaceuticals   105,426    7,221        112,647 
Real Estate Management & Development   45,587            45,587 
Software   25,589            25,589 
Transportation Infrastructure   17,639            17,639 
Total Common Stocks   540,966    7,221        548,187 
Corporate Bonds       1,602        1,602 
Short-Term Investment                    
Investment Company   2,983            2,983 
Total Assets  $543,949   $8,823   $   $552,772 

 

Transfers between investment levels may occur as the markets fluctuate and/or the availability of data used in an investment's valuation changes.